ANNX
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Annexin Pharmaceuticals is a biotechnology company developing the drug candidate ANXV, based on the protein Annexin A5, for the treatment of diseases such as vascular damage, inflammation and certain cancers. The company's partners are healthcare providers and biopharmaceutical companies and the business is aimed at global markets through research and licensing collaborations. The company was founded in 2014 and is headquartered in Stockholm, Sweden.
Read moreEPS (adj.)
Dividend %
Interim report Q2'26
Interim report Q3'26
Annual report '26
Don't miss out - create an account and get all the possible benefits